Company Filing History:
Years Active: 2019
Title: Fuminori Taniguchi: Innovator in Gynecological Therapeutics
Introduction
Fuminori Taniguchi is a notable inventor based in Tottori, Japan. He has made significant contributions to the field of gynecological therapeutics, particularly through his innovative patent addressing estrogen-dependent diseases.
Latest Patents
Taniguchi holds a patent for an "Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using same." This invention aims to provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterine adenomyosis. The solution involves using an estrogen receptor α-inhibiting β partial agonist, represented by a specific formula, as an active ingredient.
Career Highlights
Throughout his career, Taniguchi has worked with reputable organizations, including Nobelpharma Co., Ltd. and Tottori University. His work has focused on developing effective treatments for gynecological conditions, showcasing his dedication to improving women's health.
Collaborations
Taniguchi has collaborated with esteemed colleagues such as Kenichiro Nakao and Tasuku Harada. These partnerships have contributed to the advancement of research and development in his field.
Conclusion
Fuminori Taniguchi's innovative work in gynecological therapeutics highlights his commitment to addressing critical health issues. His patent represents a significant step forward in the treatment of estrogen-dependent diseases, showcasing the impact of his contributions to medical science.